Press Releases
TeraRecon announces FDA clearance
for its integrated 2D/3D image viewing station IiVS.
San Mateo, CA--May
26, 2000:
TeraRecon is proud to announce
FDA clearance for its integrated 2D/3D image viewing station IiVS.
This will allow the company to begin marketing the device in the US.
The positive review of our 510(k) premarket notification marks an
important milestone in our effort to bring revolutionary performance
and exceptional functionality into the clinical routine.
About TeraRecon, Inc.
TeraRecon, Inc. is a technology-driven provider of advanced 3D imaging
systems for medical and other visualization applications, with solutions
based on its unique and patented image processing technologies. The
company has developed a leading portfolio of products that advance
the performance, quality, functionality, and integration of image
processing and 3D visualization systems. Founded in 1997, TeraRecon
has developed a unique family of powerful processors that are used
in its real-time diagnostic workstations, enterprise-wide 3D imaging
servers using thin-client PCs, color Doppler ultrasound systems, mini
gamma cameras, high performance reconstruction engines, and real-time
volume rendering hardware engines. TeraRecon is a fast growing, privately
held company with headquarters in San Mateo, CA, and branch offices
in Concord, MA; Tokyo, Japan; Osaka, Japan; and Trondheim, Norway.
Contact:
TeraRecon, Inc.
Robert Taylor, Ph.D.
COO & Executive VP
650.372.1100
taylor@terarecon.com
www.terarecon.com
|
